News
Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...
1d
News-Medical.Net on MSNTirzepatide rewires appetite and slashes calorie intake in new obesity trialA 6-week randomized trial found that tirzepatide significantly reduced energy intake, appetite, and cravings in adults with ...
In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...
SAN FRANCISCO (Reuters) -In what she calls the "wild west" of obesity medicines, Missouri-based Amy Spencer is a pioneer.
Emma Wilkinson speaks to GPs across England as they raise the alarm over a chaotic rollout of weight-loss drug Mounjaro on ...
GIRLS actress Jenny Mollen has revealed she was rushed to hospital following a terrifying reaction to a fat-dissolving ...
54m
inews.co.uk on MSNGPs swamped by requests for NHS Mounjaro - but no one qualifiesThousands taking Mounjaro privately are inundating GP surgeries - clogging phone lines, exacerbating the 8am scramble for ...
The UK’s drug regulator is to study possible serious side effects of glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro). Data from ...
In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...
As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...
Editor Sofia Lind questions the lack of planning, support and infrastructure for GPs among the rollout of tirzepatide in ...
With Mounjaro being rolled out at GPs down south, experts have listed the reasons why people getting the jabs may still not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results